JP2016520534A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016520534A5 JP2016520534A5 JP2016503642A JP2016503642A JP2016520534A5 JP 2016520534 A5 JP2016520534 A5 JP 2016520534A5 JP 2016503642 A JP2016503642 A JP 2016503642A JP 2016503642 A JP2016503642 A JP 2016503642A JP 2016520534 A5 JP2016520534 A5 JP 2016520534A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- seq
- sequence
- nucleic acid
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108020001507 fusion proteins Proteins 0.000 claims 13
- 102000037865 fusion proteins Human genes 0.000 claims 13
- 239000000427 antigen Substances 0.000 claims 9
- 102000036639 antigens Human genes 0.000 claims 9
- 108091007433 antigens Proteins 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 7
- 150000007523 nucleic acids Chemical class 0.000 claims 7
- 102000011931 Nucleoproteins Human genes 0.000 claims 6
- 108010061100 Nucleoproteins Proteins 0.000 claims 6
- 230000002163 immunogen Effects 0.000 claims 5
- 102100037084 C4b-binding protein alpha chain Human genes 0.000 claims 4
- 101710159767 C4b-binding protein alpha chain Proteins 0.000 claims 4
- 241000287828 Gallus gallus Species 0.000 claims 4
- 238000006384 oligomerization reaction Methods 0.000 claims 4
- 102000014914 Carrier Proteins Human genes 0.000 claims 3
- 108010078791 Carrier Proteins Proteins 0.000 claims 3
- 206010022000 influenza Diseases 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000003834 intracellular effect Effects 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 108091036414 Polyinosinic:polycytidylic acid Proteins 0.000 claims 1
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 238000009169 immunotherapy Methods 0.000 claims 1
- 208000037797 influenza A Diseases 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 239000012646 vaccine adjuvant Substances 0.000 claims 1
- 229940124931 vaccine adjuvant Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305320.7 | 2013-03-18 | ||
| EP13305320 | 2013-03-18 | ||
| PCT/EP2014/055438 WO2014147087A1 (en) | 2013-03-18 | 2014-03-18 | Influenza nucleoprotein vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016520534A JP2016520534A (ja) | 2016-07-14 |
| JP2016520534A5 true JP2016520534A5 (enExample) | 2017-04-13 |
Family
ID=48044708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503642A Pending JP2016520534A (ja) | 2013-03-18 | 2014-03-18 | インフルエンザ核タンパク質ワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9243047B2 (enExample) |
| EP (1) | EP2976357B1 (enExample) |
| JP (1) | JP2016520534A (enExample) |
| KR (1) | KR102379951B1 (enExample) |
| CN (2) | CN105143251B (enExample) |
| AU (1) | AU2014234363B2 (enExample) |
| BR (1) | BR112015023738B8 (enExample) |
| CA (1) | CA2901888C (enExample) |
| MX (1) | MX363149B (enExample) |
| RU (1) | RU2662667C2 (enExample) |
| WO (1) | WO2014147087A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013357367B2 (en) * | 2012-12-11 | 2019-10-24 | Osivax Sas | Modified coiled coil type proteins having improved properties |
| US20220184200A1 (en) * | 2019-03-21 | 2022-06-16 | Georgia State University Research Foundation, Inc. | Virus-like particles and uses thereof |
| AU2022334800A1 (en) | 2021-08-24 | 2024-02-15 | Osivax | Immunogenic compositions and their use |
| US20250121053A1 (en) | 2021-12-22 | 2025-04-17 | Osivax | Vaccine compositions and their use |
| WO2023180394A1 (en) | 2022-03-22 | 2023-09-28 | Osivax | Mrna vaccine compositions and their use |
| CN115779079A (zh) * | 2022-10-01 | 2023-03-14 | 中国人民解放军军事科学院军事医学研究院 | 一种可增强与佐剂协同免疫效力的电荷调控型抗原蛋白 |
| CN117659138B (zh) * | 2023-12-25 | 2025-04-08 | 华中农业大学 | 一种流感病毒np蛋白突变体及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL108915A0 (en) * | 1993-03-18 | 1994-06-24 | Merck & Co Inc | Polynucleotide vaccine against influenza virus |
| AU9222598A (en) * | 1997-09-04 | 1999-03-22 | Stanford University | Reversible immobilization of arginine-tagged moieties on a silicate surface |
| AU2003263212A1 (en) * | 2002-08-14 | 2004-03-03 | Avidis Sa | Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| CA2535517A1 (en) * | 2003-08-12 | 2005-02-17 | Avidis Sa | Product comprising a c4bp core protein and a monomeric antigen, and its use |
| EP1795540A1 (en) * | 2005-11-30 | 2007-06-13 | Imaxio | Multimeric complexes of antigens and an adjuvant |
| EP2060586A1 (en) * | 2007-11-14 | 2009-05-20 | PharmaSurgics in Sweden AB | New synthetic arginine substituted peptides and their use |
| GB0918154D0 (en) * | 2009-10-16 | 2009-12-02 | Isis Innovation | Mycobacterial vaccines |
| AU2013357367B2 (en) * | 2012-12-11 | 2019-10-24 | Osivax Sas | Modified coiled coil type proteins having improved properties |
-
2014
- 2014-03-18 AU AU2014234363A patent/AU2014234363B2/en active Active
- 2014-03-18 BR BR112015023738A patent/BR112015023738B8/pt active Search and Examination
- 2014-03-18 JP JP2016503642A patent/JP2016520534A/ja active Pending
- 2014-03-18 KR KR1020157029403A patent/KR102379951B1/ko active Active
- 2014-03-18 RU RU2015140603A patent/RU2662667C2/ru active
- 2014-03-18 WO PCT/EP2014/055438 patent/WO2014147087A1/en not_active Ceased
- 2014-03-18 CN CN201480013364.1A patent/CN105143251B/zh active Active
- 2014-03-18 CA CA2901888A patent/CA2901888C/en active Active
- 2014-03-18 MX MX2015013304A patent/MX363149B/es unknown
- 2014-03-18 EP EP14710594.4A patent/EP2976357B1/en active Active
- 2014-03-18 CN CN202110430609.2A patent/CN113307881A/zh active Pending
- 2014-12-15 US US14/570,155 patent/US9243047B2/en active Active
-
2015
- 2015-12-21 US US14/975,918 patent/US9963490B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016520534A5 (enExample) | ||
| JP2016510983A5 (enExample) | ||
| EA201892250A1 (ru) | Вакцина против rsv | |
| JP2015525217A5 (enExample) | ||
| JP2016199557A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| SA518390954B1 (ar) | لقاحات علاجية لفيروس الورم الحليمي البشري 18 | |
| JP2013507907A5 (enExample) | ||
| BR112015001390A2 (pt) | vacina de proteína de fusão multimérica e imunoterápicos | |
| EA202090738A1 (ru) | Способ безопасного индуцирования иммунитета против rsv | |
| RU2015140603A (ru) | Вакцины на основе нуклеопротеина вируса гриппа | |
| JP2015212284A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| BR112013032723A2 (pt) | antígenos amplamente reativos computacionalmente otimizados para influenza h1n1 | |
| JP2016539946A5 (enExample) | ||
| MX340735B (es) | Proteinas multimericas recombinantes de la influenza. | |
| JP2015529678A5 (enExample) | ||
| JP2016509011A5 (enExample) | ||
| BR112014018884A2 (pt) | antígenos amplamente reativos computacionalmente otimizados para viroses de influenza h3n2, h2n2, e b | |
| JP2015524422A5 (enExample) | ||
| RU2014135053A (ru) | Иммуногены для вакцинации против вич | |
| EA201990718A1 (ru) | Векторы аденовируса собачьих | |
| JP2016504993A5 (enExample) | ||
| JP2015524403A5 (enExample) | ||
| AR128395A2 (es) | Péptidos novedosos capaces de inducir la formación de anticuerpos contra pcsk9 |